Newtown Medical Manufacturing Firm Benefitting from Part of £2.5million Approved to Help Welsh Businesses Cope with Brexit Challenges

Wednesday August 14th, 2019

Almost £2.5million has been approved to help Welsh businesses adjust to the challenges of Brexit since the Welsh Government’s Brexit Business Resilience Programme was launched last year, Economy Minister Ken Skates has announced.Government Opportunities

A total of 51 eligible businesses have been approved for funding of between £10,000 and £100,000 as part of the Brexit Business Resilience Grant Fund, so they can invest in overcoming immediate challenges related to Brexit.

Among the companies to have benefitted from the support is Newtown-based medical manufacturing firm Splice Cast – who provide a flagship range of life saving cervical cancer detection instruments.

After identifying potentially negative impacts on its logistical and supply requirements, the firm applied for a Brexit Resilience Grant totalling £48,595.

This enabled the company to invest in additional warehouse space to hold larger stocks of raw materials and finished goods to protect from them from border delays and interrupted supplies.

The Brexit Business Resilience Grant Fund is currently fully committed, but work is under way to make more funding available.

To find out more about the support available visit Business Wales.

Economy Minister Ken Skates said:

“The threat of a no deal Brexit continues to cause deep uncertainty in our economy, threatening jobs and people’s livelihoods.

Many businesses have engaged with the Brexit Resilience Grant Fund we established to help future proof our economy and work with the business sector to prepare for the challenges ahead.

It is clear that this support is helping companies across Wales to navigate immediate Brexit burdens and uncertainties and to develop new collaborations and innovations. I would urge any Welsh company to find out how Business Wales can help them manage and prepare for the ongoing uncertainties of Brexit.”

Leave a Reply